DUBLIN--(BUSINESS WIRE)--The "Nasal Polyps Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering.
A new study on the global nasal polyps treatment market presents a wealth of information on the key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the nasal polyps treatment market. This study offers valuable information about the nasal polyps treatment market, to illustrate how growth will discern during the forecast period of 2019-2027.
Key indicators of market growth, which include value chain as well as supply chain analysis, and Compound Annual Growth Rate (CAGR), are elucidated in This study in a comprehensive manner. This data can help readers interpret the quantitative growth aspects of the nasal polyps treatment market during the forecast period.
An extensive analysis on leading market players' business strategies is also featured in This study on the nasal polyps treatment market. This can help readers understand principal factors to foresee growth in the nasal polyps treatment market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the nasal polyps treatment market, which will guide market players in making apt decisions in the future.
Key Questions Answered in the Nasal Polyps Treatment Market Study
- What is the scope of growth of nasal polyps treatment companies in the surgical treatment sector?
- What will be the Y-o-Y growth of the nasal polyps treatment market between 2019 and 2027?
- What is the influence of the changing trends in technologies on the nasal polyps treatment market?
- Will North America continue to remain the most profitable regional market for nasal polyps treatment providers?
- Which factors will impede the growth of the nasal polyps treatment market during the forecast period?
- Which are the leading companies in the global nasal polyps treatment market?
Key Topics Covered:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nasal Polyps Treatment Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.4. Global Nasal Polyps Treatment Market Analysis and Forecast, 2017-2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Key Industry Developments
5.2. Pipeline Analysis
5.3. Qualitative Assessment on Novel Treatment Options for Nasal Polyps: Biologics & Stents
5.3.1. Key Insights on Biologics (Xolair, Dupixent, Nucala)
6. Global Nasal Polyps Treatment Market Analysis and Forecast, by Type of Treatment
6.1. Introduction & Definition
6.2. Market Value Forecast, by Type of Treatment , 2017-2027
6.3. Market Attractiveness By Type of Treatment
7. Global Nasal Polyps Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Market Value Forecast, by End-user, 2017-2027
7.3. Market Attractiveness, by End-user
8. Global Nasal Polyps Treatment Market Analysis and Forecast, by Region
8.1. Introduction
8.2. Market Value Forecast, by Region
8.3. Market Attractiveness, by Country/Region
9. North America Nasal Polyps Treatment Market Analysis and Forecast
9.1. Introduction
9.2. Market Value Forecast, by Type of Treatment , 2017-2027
9.3. Market Value Forecast, by End-user, 2017-2027
9.4. Market Value Forecast, by Country, 2017-2027
9.5. Market Attractiveness Analysis
10. Europe Nasal Polyps Treatment Market Analysis and Forecast
11. Asia Pacific Nasal Polyps Treatment Market Analysis and Forecast
12. Latin America Nasal Polyps Treatment Market Analysis and Forecast
13. Middle East & Africa Nasal Polyps Treatment Market Analysis and Forecast
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Global Nasal Polyps Treatment Market Position Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. OptiNose US, Inc.
14.3.2. Regeneron Pharmaceuticals, Inc.
14.3.3. Merck & Co., Inc.
14.3.4. Pfizer, Inc.
14.3.5. F. Hoffmann La-Roche, Ltd.
14.3.6. Intersect ENT, Inc.
14.3.7. GlaxoSmithKline plc
14.3.8. Sanofi
14.3.9. Novartis AG
For more information about this report visit https://www.researchandmarkets.com/r/3cyfks
